Alkeran

Alkeran Warnings and Precautions

• Severe bone marrow suppression: Leukopenia, thrombocytopenia, and anemia are common and can be severe; irreversible bone marrow failure has been reported. The IV formulation causes more myelosuppression than the oral form.
• Carcinogenic potential: Melphalan is leukemogenic in humans and should be considered potentially mutagenic.
• Hypersensitivity reactions: Including anaphylaxis, have occurred in a small percentage of patients receiving the IV formulation.
• Hepatic disorders: Ranging from abnormal liver function tests to hepatitis and jaundice have been reported.
• Gastrointestinal effects: Nausea, vomiting, diarrhea, and oral ulceration may occur.

How to Access Alkeran in India: A 6-Step Process

Step 1 – Search & request your medicine: The patient or treating doctor submits a request with basic details to initiate the access process.

Step 2 – Verification & eligibility review: The team verifies availability and reviews eligibility against regulatory and clinical requirements to ensure a compliant pathway.

Step 3 – Receive quote & delivery timeline: A transparent quotation is shared, covering medicine cost, logistics, and a clear delivery timeline.

Step 4 – Regulatory approval process: Assistance is provided to secure the approvals and documentation required for legal cross-border access.

Step 5 – Temperature-controlled import & handling: The medicine is sourced and transported under strict GDP-compliant conditions to maintain product integrity.

Step 6 – Secure delivery: The medicine is delivered to the patient or treating hospital, with updates provided at each stage.

Note: From request to delivery, every step is designed to ensure your treatment reaches you safely, compliantly, and without unnecessary delays.

Documentation & Availability

What documents are required to import Alkeran to India?

Alkeran (melphalan) injection may be imported in the patient's name only, by patients or government hospitals, in line with India's import regulations for unapproved medicines. The following documentation is required:

• A valid prescription from a qualified doctor
• The patient's diagnostic reports and treatment plan
• Patient ID proof (issued by the Government of India)

How is the order confirmed?

The order is confirmed only after receipt and verification of a valid prescription from the doctor and, if applicable, an import permit.

Is Alkeran available in India?

Alkeran (melphalan injection) is a prescription medicine that legally requires a doctor's prescription to be dispensed. As of current publicly available information, Alkeran is not commercially marketed in India under this brand.

However, patients in India can legally access Alkeran through the Named Patient Program (NPP) — an import provision that allows a medicine not yet registered in India to be imported in the name of a specific patient for their personal treatment, under a valid prescription.

Alkeran has been FDA approved for decades, ensuring full transparency throughout the process.

Alkeran can be made available to patients, doctors, and hospitals across major cities in India, including Gurgaon, Delhi, Bangalore, Mumbai, Navi Mumbai, Thane, Hyderabad, Mysore, Kerala, Chennai, Coimbatore, Madurai, Kolkata, Ahmedabad, Surat, Vadodara, Pune, Nagpur, Nashik, Jaipur, Udaipur, Lucknow, Kanpur, Gorakhpur, Chandigarh, Mohali, Faridabad, Noida, Ghaziabad, Kochi, Trivandrum, Kozhikode, Thrissur, Kannur, Mangalore, Bhubaneswar, Patna, Ranchi, Raipur, Guwahati, Visakhapatnam, Vijayawada, Goa, Jammu, Srinagar, Dehradun, Bhopal, Indore, Ludhiana, Amritsar, and others — and can facilitate delivery to the patient's treating hospital. Orders are confirmed only after receipt of a valid doctor's prescription and an import permit, where applicable.

Sourcing & Delivery

NamedPatientProgram.com (NPP) can source Alkeran from reliable global channels and facilitate supply to patients, doctors, and hospitals under applicable legal provisions. The Alkeran injection vial should be stored at controlled room temperature, 15°C to 30°C, protected from light — note that Alkeran oral tablets, a separate formulation, require refrigerated storage instead. Handling follows temperature-controlled shipping conditions throughout transit. All prescriptions are dispensed and checked by registered pharmacists and dispatched from New Delhi, India, after legal requirements are fulfilled.

For Alkeran cost in India and availability, contact NPP via WhatsApp at +91 98104 69557 | Toll-Free: 1800-1200-365 or email info@namedpatientprogram.com.

Availability of Alkeran Across Major Cities in India

Patients across India can access Alkeran through regulated import pathways, with delivery arranged to the treating hospital based on a valid oncologist's prescription.

Mumbai

A major oncology hub with institutions like Tata Memorial, Mumbai coordinates access to chemotherapy agents like Alkeran for eligible patients.

Delhi

As part of the Delhi NCR region, the city has a strong concentration of cancer centers, making it a key location for accessing multiple myeloma treatments.

Bangalore

With a growing network of multispecialty oncology hospitals, Bangalore supports access to Alkeran through structured import pathways guided by treating specialists.

Chennai

Home to several reputed cancer treatment centers, Chennai facilitates access to Alkeran for patients undergoing chemotherapy for multiple myeloma.

Hyderabad

A growing hub for oncology care, Hyderabad supports coordinated access to Alkeran for eligible patients under specialist supervision.

Kolkata

Eastern India's leading cancer centers in Kolkata coordinate Alkeran access for patients undergoing chemotherapy.

Pune

With an expanding base of oncology clinics, Pune facilitates timely access to Alkeran under prescription.

Ahmedabad

Gujarat's leading cancer hospitals support regulated access to Alkeran for eligible patients.

Kochi

Kerala's healthcare network, including major cancer centers in Kochi, coordinates access to chemotherapy agents like Alkeran.

Chandigarh

Serving North India, Chandigarh's oncology centers facilitate access to Alkeran for patients from Punjab, Haryana, and Himachal Pradesh.

Jaipur

Rajasthan's leading hospitals support patient access to Alkeran through the Named Patient Program.

Lucknow

A key referral center for North India, Lucknow facilitates coordinated access to Alkeran under oncologist care.

Bhubaneswar

Odisha's growing oncology sector supports patient access to Alkeran.

Guwahati

As a referral hub for the North-East, Guwahati facilitates access to Alkeran for patients across the region.

Access can also be coordinated for patients in other major Indian cities, subject to a valid prescription and regulatory requirements.